ArticleCardiology journal2024
SELECT semaglutide to improve outcomes in patients with obesity and cardiovascular disease, also without diabetes.
Grzegorz GajosPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it